resveratrol has been researched along with Spinal Cord Injuries in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (19.35) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 12 (38.71) | 2.80 |
| Authors | Studies |
|---|---|
| Coronel, MF; Mazzone, GL; Miguel, CA; Noya-Riobó, MV; Villar, MJ | 1 |
| Chen, J; Hu, J; Xiang, Z; Xu, H; Xu, L; Yao, X; Yin, C; Zhang, S | 1 |
| An, J; Li, Y; Mei, X; Tian, H; Tong, L; Wu, C; Wu, Q; Zou, Z | 1 |
| Cao, X; Chen, J; Chen, YY; Fu, C; He, N; Jin, X; Li, H; Li, J; Li, Y; Liu, S; Shen, G; Shen, Y; Shi, D; Song, X; Wang, J; Wang, LL; Xu, L; Zhao, T; Zheng, M; Zhong, J | 1 |
| Cheng, R; Fang, M; Fang, Z; Jiao, D; Mi, X; Ni, C; Ye, Q; Ye, X; Zhang, S | 1 |
| Botchway, BOA; Huang, M; Liu, X; Tang, S; Wang, X; Zhang, Y | 1 |
| Feng, S; Fu, X; Hu, W; Kan, S; Liu, C; Ma, B; Zhao, X; Zhou, M; Zhu, H; Zhu, R | 1 |
| Fan, X; Li, S; Liu, Z; Lu, Y; Ma, Z; Wang, X; Yang, J | 1 |
| Fan, Y; Huang, S; Li, H; Li, Y; Liu, B; Xu, H | 1 |
| Chen, W; Song, Q; Zhang, L; Zhao, S; Zhao, Z | 1 |
| Mei, X; Tu, G; Yang, D; Zhao, H | 1 |
| Botchway, BOA; Fan, R; Liu, X; Zhang, Y | 1 |
| Abdioglu, AA; Aydin, HE; Bozkurt, I; Guney, G; Paksoy, K; Senturk, S; Yaman, ME | 1 |
| Botchway, BOA; Huo, X; Liu, X; Meng, X; Xu, L; Zhang, S; Zhou, J | 1 |
| Huang, XD; Li, H; Meng, HY; Niu, HY; Shao, DC; Xu, B; Yang, G | 1 |
| Botchway, BOA; Fang, M; Liu, X; Tan, X; Zhang, Y | 1 |
| Liu, Y; Sha, C; Xu, L; Xu, W; Zhang, G; Zhang, H | 1 |
| Botchway, BOA; Liu, X; Zhang, S; Zhang, Y | 1 |
| Agrawal, SK; Atif, F; Kesherwani, V; Yousuf, S | 1 |
| Guo, JD; Hou, SX; Li, L; Shi, YM; Wang, HD; Zhang, YP | 1 |
| Chen, JM; Fan, RX; Fan, XP; Fu, Q; Guo, HM; Li, XH; Zhou, ZF; Zhu, P; Zhuang, J | 1 |
| Liu, J; Sun, T; Xiang, Z; Yi, L; Zhang, H; Zhong, J | 1 |
| Baydemir, C; Çiftçi, U; Delen, E; Doğaner, F; Turgut Coşan, D; Uysal, O; Vural, M | 1 |
| Chen, S; Gao, K; Guo, Y; Li, Z; Liu, C; Mei, X; Shen, Z; Wan, Z; Wang, C; Zhao, H; Zhou, Z | 1 |
| Fan, L; Liu, C; Shi, Z; Wang, B; Wang, K; Zhang, C | 1 |
| Piao, Y; Yang, Y | 1 |
| Piao, YJ; Yang, YB | 1 |
| Bisleri, G; Cheema, FH; Kaplan, S; Morgan, JA; Oz, MC | 1 |
| Kern, J | 1 |
| Altinoz, E; Ates, O; Cayli, S; Gurses, I; Kocak, A; Turkoz, Y; Yologlu, S; Yucel, N | 1 |
| Akar, F; Budak, B; Katircioğlu, SF; Seren, M; Sürücü, S; Turan, NN; Tütün, U; Ulus, AT; Yazicioğlu, H | 1 |
5 review(s) available for resveratrol and Spinal Cord Injuries
| Article | Year |
|---|---|
Antioxidant, anti-inflammatory and neuroprotective actions of resveratrol after experimental nervous system insults. Special focus on the molecular mechanisms involved.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Brain Injuries; Cell Death; Humans; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Resveratrol; Spinal Cord Injuries | 2021 |
Research progress in use of traditional Chinese medicine for treatment of spinal cord injury.
Topics: Curcumin; Ginsenosides; Humans; Medicine, Chinese Traditional; Paclitaxel; Resveratrol; Spinal Cord Injuries | 2020 |
Resveratrol Can Attenuate Astrocyte Activation to Treat Spinal Cord Injury by Inhibiting Inflammatory Responses.
Topics: Animals; Astrocytes; Gliosis; Inflammasomes; Models, Immunological; Nerve Tissue Proteins; Neuroinflammatory Diseases; NF-kappa B; NLR Proteins; Recovery of Function; Resveratrol; Spinal Cord Injuries; Toll-Like Receptors | 2021 |
Beneficial Effects of Resveratrol-Mediated Inhibition of the mTOR Pathway in Spinal Cord Injury.
Topics: Animals; Apoptosis; Autophagy; Cell Proliferation; Humans; Neurons; Resveratrol; Signal Transduction; Spinal Cord; Spinal Cord Injuries; TOR Serine-Threonine Kinases | 2018 |
Resveratrol can inhibit Notch signaling pathway to improve spinal cord injury.
Topics: Animals; Enzyme Inhibitors; Humans; Neuroprotective Agents; Receptors, Notch; Resveratrol; Signal Transduction; Spinal Cord Injuries | 2019 |
26 other study(ies) available for resveratrol and Spinal Cord Injuries
| Article | Year |
|---|---|
Resveratrol promotes axonal regeneration after spinal cord injury through activating Wnt/β-catenin signaling pathway.
Topics: Animals; Axons; Nerve Regeneration; Neuroprotective Agents; Rats; Recovery of Function; Resveratrol; Spinal Cord; Spinal Cord Injuries; Wnt Signaling Pathway | 2021 |
Chitosan-modified hollow manganese dioxide nanoparticles loaded with resveratrol for the treatment of spinal cord injury.
Topics: Animals; Apoptosis; Caspase 3; Chitosan; Manganese Compounds; Nanoparticles; Oxidative Stress; Oxides; Rats; Rats, Sprague-Dawley; Resveratrol; Spinal Cord Injuries | 2022 |
Resveratrol suppresses microglial activation and promotes functional recovery of traumatic spinal cord via improving intestinal microbiota.
Topics: Animals; Anti-Inflammatory Agents; Butyrates; Dysbiosis; Fatty Acids, Volatile; Gastrointestinal Microbiome; Mice; Microglia; Resveratrol; RNA, Ribosomal, 16S; Spinal Cord Injuries | 2022 |
Resveratrol inhibits ferroptosis via activating NRF2/GPX4 pathway in mice with spinal cord injury.
Topics: Animals; Ferroptosis; Iron; Mice; NF-E2-Related Factor 2; Phospholipid Hydroperoxide Glutathione Peroxidase; Resveratrol; Spinal Cord; Spinal Cord Injuries | 2023 |
Resveratrol can improve spinal cord injury by activating Nrf2/HO-1 signaling pathway.
Topics: Antioxidants; Humans; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol; Signal Transduction; Spinal Cord; Spinal Cord Injuries | 2024 |
Resveratrol improves the prognosis of rats after spinal cord injury by inhibiting mitogen-activated protein kinases signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Interleukin-6; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prognosis; Rats; Rats, Sprague-Dawley; Recovery of Function; Resveratrol; Signal Transduction; Spinal Cord; Spinal Cord Injuries; Tumor Necrosis Factor-alpha | 2023 |
Resveratrol-primed exosomes strongly promote the recovery of motor function in SCI rats by activating autophagy and inhibiting apoptosis via the PI3K signaling pathway.
Topics: Animals; Apoptosis; Autophagy; Drug Carriers; Exosomes; Male; Microglia; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Recovery of Function; Resveratrol; Signal Transduction; Spinal Cord Injuries | 2020 |
Resveratrol and Puerarin loaded polymeric nanoparticles to enhance the chemotherapeutic efficacy in spinal cord injury.
Topics: Animals; Drug Carriers; Isoflavones; Male; Malondialdehyde; Nanoparticles; Oxidative Stress; Polymers; Rats; Resveratrol; Spinal Cord Injuries | 2020 |
Resveratrol inhibits inflammation after spinal cord injury via SIRT-1/NF-κB signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Female; Inflammation; Neuroprotective Agents; NF-kappa B; Rats; Rats, Sprague-Dawley; Recovery of Function; Resveratrol; Signal Transduction; Sirtuin 1; Spinal Cord Injuries | 2021 |
Effects of Resveratrol on Inflammation and Apoptosis After Experimental Spinal Cord Injury.
Topics: Animals; Apoptosis; Disease Models, Animal; Inflammation; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Resveratrol; Spinal Cord; Spinal Cord Injuries | 2018 |
Resveratrol improves neurological outcome and neuroinflammation following spinal cord injury through enhancing autophagy involving the AMPK/mTOR pathway.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Inflammation; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Spinal Cord Injuries; Stilbenes; TOR Serine-Threonine Kinases | 2018 |
Resveratrol treatment of spinal cord injury in rat model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; bcl-2-Associated X Protein; Caspase 3; Disease Models, Animal; GAP-43 Protein; Inflammation; Male; Methylprednisolone; Microscopy, Electron; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Resveratrol; Spinal Cord Injuries | 2019 |
Resveratrol alleviates lipopolysaccharide-induced inflammation in PC-12 cells and in rat model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Disease Models, Animal; Inflammation; Inflammation Mediators; Lipopolysaccharides; MicroRNAs; PC12 Cells; Rats; Resveratrol; Signal Transduction; Spinal Cord Injuries | 2019 |
Resveratrol protects spinal cord dorsal column from hypoxic injury by activating Nrf-2.
Topics: Animals; Antioxidants; Blotting, Western; Fluorescent Antibody Technique; Hypoxia; Immunohistochemistry; Male; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Spinal Cord; Spinal Cord Injuries; Stilbenes | 2013 |
Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Disease Models, Animal; Femur; Gene Expression Regulation; Inflammation Mediators; Male; Malondialdehyde; Osteoporosis; Oxidative Stress; Radiography; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Signal Transduction; Spinal Cord Injuries; Stilbenes; Sulfhydryl Compounds; Tibia | 2013 |
[Protective effect of retrograde venous perfusion of cryogenic liquid via accessory hemiazygos vein and treated with resveratrol on spinal cord injury in swine].
Topics: Animals; Hypothermia, Induced; Male; Microtubule-Associated Proteins; Reperfusion Injury; Resveratrol; Spinal Cord; Spinal Cord Injuries; Stilbenes; Swine | 2013 |
Resveratrol attenuates spinal cord injury-induced inflammatory damage in rat lungs.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; Female; Inflammation; Lung; Lung Diseases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Spinal Cord Injuries; Stilbenes | 2015 |
Efficiacy of resveratrol and quercetin after experimental spinal cord injury.
Topics: Animals; Antioxidants; Disease Models, Animal; Inflammation; Male; Oxidative Stress; Quercetin; Rats; Rats, Sprague-Dawley; Resveratrol; Spinal Cord Injuries; Stilbenes | 2016 |
Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway.
Topics: Adenylate Kinase; Animals; Apoptosis; Autophagy; Beclin-1; Caspase 3; Caspase 9; Female; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Sirtuin 1; Spinal Cord; Spinal Cord Injuries; Stilbenes | 2017 |
Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury.
Topics: Animals; Disease Models, Animal; Motor Activity; Neurons; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Resveratrol; Spinal Cord Injuries; Stilbenes | 2011 |
[Effects of resveratrol on Ca2+, Mg(2+)-ATPase activities after spinal cord trauma in rats].
Topics: Animals; Ca(2+) Mg(2+)-ATPase; Drugs, Chinese Herbal; Female; Male; Methylprednisolone; Rats; Rats, Sprague-Dawley; Resveratrol; Spinal Cord Injuries; Stilbenes | 2002 |
Effects of resveratrol on secondary damages after acute spinal cord injury in rats.
Topics: Acute Disease; Animals; Edema; Female; L-Lactate Dehydrogenase; Male; Malondialdehyde; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Resveratrol; Sodium-Potassium-Exchanging ATPase; Spinal Cord Injuries; Stilbenes | 2003 |
Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury.
Topics: Animals; Male; Phenols; Rabbits; Reperfusion Injury; Resveratrol; Spinal Cord Injuries; Stilbenes; Wine | 2005 |
Invited commentary.
Topics: Animals; Phenols; Rabbits; Reperfusion Injury; Resveratrol; Spinal Cord Injuries; Stilbenes; Wine | 2005 |
Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury.
Topics: Animals; Glutathione; Male; Malondialdehyde; Methylprednisolone; Motor Activity; Neuroprotective Agents; Nitric Oxide; Rats; Rats, Wistar; Resveratrol; Spinal Cord; Spinal Cord Injuries; Stilbenes; Xanthine Oxidase | 2006 |
In which period of injury is resveratrol treatment effective: ischemia or reperfusion?
Topics: Analysis of Variance; Animals; Antioxidants; Apoptosis; Disease Models, Animal; Enzyme Inhibitors; Hindlimb; Immunohistochemistry; Ischemic Preconditioning; Lumbar Vertebrae; Malondialdehyde; Microscopy, Electron; Movement; NG-Nitroarginine Methyl Ester; Nitrates; Nitrites; Peroxidase; Rabbits; Recovery of Function; Reperfusion; Reperfusion Injury; Resveratrol; Spinal Cord Injuries; Stilbenes; Time Factors; Treatment Outcome | 2007 |